These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
382 related items for PubMed ID: 10487666
1. Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial. Sas T, de Waal W, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A. J Clin Endocrinol Metab; 1999 Sep; 84(9):3064-70. PubMed ID: 10487666 [Abstract] [Full Text] [Related]
5. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K. J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836 [Abstract] [Full Text] [Related]
6. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment. Boguszewski M, Bjarnason R, Rosberg S, Carlsson LM, Albertsson-Wikland K. J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566 [Abstract] [Full Text] [Related]
7. Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age. van Pareren YK, Duivenvoorden HJ, Slijper FS, Koot HM, Hokken-Koelega AC. J Clin Endocrinol Metab; 2004 Nov; 89(11):5295-302. PubMed ID: 15531473 [Abstract] [Full Text] [Related]
14. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone. van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Delemarre-van de Waal HA, Vulsma T, Wit JM, Rouwé CW, Reeser HM, Gosen JJ, Rongen-Westerlaken C, Drop SL. J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853 [Abstract] [Full Text] [Related]
16. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age. Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G. Horm Res; 2005 Nov; 64(2):68-76. PubMed ID: 16113581 [Abstract] [Full Text] [Related]
18. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frölich M, Oostdijk W, Wit JM. J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153 [Abstract] [Full Text] [Related]
19. Prediction model for adult height of small for gestational age children at the start of growth hormone treatment. de Ridder MA, Stijnen T, Hokken-Koelega AC. J Clin Endocrinol Metab; 2008 Feb; 93(2):477-83. PubMed ID: 18000093 [Abstract] [Full Text] [Related]
20. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. Binder G, Baur F, Schweizer R, Ranke MB. J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706 [Abstract] [Full Text] [Related] Page: [Next] [New Search]